CXCR3 gene as a therapeutic target in colorectal cancer
Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, Mehrdad Behmanesh · 2025
Read CXCR3 gene as a therapeutic target in colorectal cancer by Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, Mehrdad Behmanesh (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817714.txt.
Description
Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, and Mehrdad Behmanesh study the CXCR3 gene as a therapeutic target in colorectal cancer. Their 2025 paper notes that current treatments often fail or bring side effects, so new targets are needed.
CXCR3, a member of the GPCR family, is raised in colorectal cancer. The team designed specific DNAzymes to target the gene in the HCT-116 cancer cell line. They then assessed cell cycle, cell death by staining, and wound healing to see how lowering CXCR3 affects cancer cell growth. Downregulation held back a key AKT and MTOR related path, the opening results show.
Catalog record
| CREATOR | Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, Mehrdad Behmanesh |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |